Private equity firms often describe themselves as generalists, willing to invest across industries. Waud Capital Partners chose a different approach: deep specialization in two sectors over 30 years.
Since its 1993 founding, the firm has concentrated on healthcare services and software/technology investments. This focused strategy allows the team to develop sector expertise, build networks of industry executives, and identify subsector opportunities that generalist firms might miss.
Healthcare Services: Core Investment Territory
Healthcare represents one of Waud Capital’s two core sectors. Within healthcare, the firm targets several subsectors: behavioral health, gastroenterology practices, vision care, home infusion therapy, and medical device distribution.
Reeve B. Waud founded Acadia Healthcare in 2005 as a behavioral health platform. The company consolidated psychiatric and substance abuse treatment facilities, growing from a startup into a network of 260 facilities across 40 states and Puerto Rico. Acadia completed an IPO in 2011 and continues to operate as a publicly traded company.
GI Alliance represents another healthcare consolidation. Waud Capital partnered with physician executives in 2018 to create a gastroenterology practice management platform. Over four years, the company expanded from two states to 14 states, becoming the largest independent GI practice management company in the nation. In 2022, Waud Capital exited through a recapitalization valued at approximately $2.2 billion, with Apollo Global Management joining as a new investment partner.
The firm’s healthcare investments also include Unifeye Vision Partners (eye care practice management), PromptCare (home infusion services), and Provider Network Holdings (specialty provider networks). Most recently, in January 2025, Waud Capital acquired Mopec Group, a supplier of pathology equipment and services.
Software & Technology: Complementary Platform
Software and technology investments form Waud Capital’s second sector focus. The firm targets vertical software (industry-specific applications), healthcare IT, financial technology, and tech-enabled services.
Portfolio companies in this sector have included iOFFICE (workplace management software), which Waud Capital acquired in 2018 and sold to Thoma Bravo in 2021 after quintupling revenues in 2.5 years. Other software investments include Sphere (payment processing), PracticeTek (practice management software), and Science Exchange (research marketplace platform).
The software strategy complements healthcare investing. Many software portfolio companies serve healthcare customers, creating synergies between the firm’s two sectors. Healthcare IT companies benefit from the team’s understanding of provider operations, regulatory requirements, and reimbursement dynamics.
Executive Partner Model for Value Creation
Waud Capital employs an “Ecosystem” of operating partners—seasoned executives who assist with deal evaluation and portfolio company management. For healthcare investments, these partners might include former hospital CEOs, physician practice operators, or healthcare system executives.
“Human capital is at the heart of everything we do at WCP,” Reeve B. Waud explained. The firm maintains a five-person internal human capital team dedicated to recruiting and supporting executive talent.
Brad Staley exemplifies this model. An Executive Partner at Waud Capital with over 25 years in healthcare operating roles, Staley recently became Executive Chairman of Mopec Group following the January 2025 acquisition. He brings experience scaling organizations through organic and acquisition-driven growth, most recently as CEO of Advancing Eyecare.
The firm’s healthcare platforms average more than 10 add-on acquisitions during Waud Capital’s hold period. This buy-and-build strategy requires operational expertise to integrate acquired companies, standardize systems, and maintain culture. Executive partners provide this expertise.
Reeve B. Waud has led or overseen more than 500 company acquisitions throughout his career. For realized investments, Waud Capital reports average revenue growth exceeding 400% during the firm’s ownership. These outcomes reflect both capital deployment and operational improvement.
The firm typically invests $75 million to $200 million in equity per transaction and takes controlling stakes in portfolio companies. Control ownership enables Waud Capital to implement its executive partner model, influence company strategy, and drive the add-on acquisition programs that characterize its approach.Read: Acadia Healthcare, Majority Owned bWaud Capital Partners, Completes Merger with PHC, Inc. and Becomes Publicly Traded Company
